language_icon
EN
HI

Clinitech Laboratory Share price

CTLLAB

38

1.00 (2.70%)
Last updated on 20 Mar, 2026 | 11:01 IST
Today's High

38.37

Today's Low

38.00

52 Week Low

28.55

52 Week High

57.00

Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Clinitech Laboratory Chart

Clinitech Laboratory Share Key Metrics

Volume
3600.00
Market Cap
8.44 CR
LTQ@LTP
1200@38.00
ATP
38.12
Var Margin
100 %
Circuit Range
29.6-44.4
Delivery %
100 %
Value
1.37 L
ASM/GSM
No
Market Lot
1200

Summary

At 20 Mar, 2026 | 11:01, Clinitech Laboratory share price stands at ₹38, showing a 1.00% 2.70 for the day. The stock’s intraday movement has stayed between ₹38.00 and ₹38.37, while on a 52-week basis it has fluctuated from ₹28.55 to ₹57.00.
In terms of trading activity, Clinitech Laboratory has recorded a volume of 3600 shares, with a market capitalisation of ₹2282400. The stock’s Average Traded Price (ATP) stands at ₹3812, while the Last Traded Quantity at Last Traded Price (LTQ@LTP) is 1200,3800. The stock operates within a circuit range of ₹29.6-44.4, with a Value of ₹1.37 L. The Delivery Percentage for the day is 100%. Additionally, Clinitech Laboratory currently falls under the No framework, and trades with a market lot size of 1200.

Clinitech Laboratory Fundamentals

View More
P/E Ratio

0

P/B Ratio

0

Div. Yield

0

Sector P/E

48.82

Sector P/B

-16.74

Sec. Div. Yield

2.56

Clinitech Laboratory Resistance and Support

Pivot 37.12

Resistance

First Resistance

37.24

Second Resistance

37.47

Third Resistance

37.59

Support

First Support

36.89

Second Support

36.77

Third Support

36.54

Clinitech Laboratory Futures & Options

Data Not Found

Clinitech Laboratory Shareholding Pattern

View More
  • 2024-25
  • 2025-26
Total Promoters
Segment
Percent

Total Promoters

62.42%

Mutual Fund

0%

Insurance

0%

Foreign Institutional Investors

0.32%

Domestic Institutional Investors

0%

Retail

37.27%

Others

-0.01%

Total Promoters
MAR '25
61.58%
SEP '25
62.42%

Clinitech Laboratory Corporate Actions

DateAgenda
2025-11-22Others
2025-11-12Half Yearly Results
2025-08-19Others
2025-06-06Others
2025-05-23Audited Results
2025-03-25Others

Clinitech Laboratory News

Clinitech Laboratory Ltd - 544220 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Clinitech Laboratory's Promoter & Managing Director, Jagdish Umakant Nayak, acquired 4,800 equity shares, increasing his and PACs' holding to 63.99%. This transaction, conducted through open market purchases, took place on March 19 and 20, 2026.
Mar 20 2026 17:03:00

Clinitech Laboratory Ltd - 544220 - Disclosures under Reg. 29(2) of SEBI (SAST) Regulations, 2011

Clinitech Laboratory's promoter, Jagdish Umakant Nayak, acquired 4,800 equity shares through the open market on March 17-18, 2026. This acquisition increased the promoter's total holding from 63.57% to 63.78%. The shares were purchased by the Promoter and Persons Acting in Concert (PACs).
Mar 18 2026 17:03:00
Read More

About Clinitech Laboratory

NSE : 0  
BSE : 544220  
ISIN : INE0QMR01015  

Our Company was incorporated as Clinitech Laboratory Private Limited on March 19 2010 under the Companies Act 1956 with the Registrar of Companies Mumbai bearing Registration number 201078. The status of the Company was changed to public limited and the name of our Company was changed to Clinitech Laboratory Limited vide Special Resolution dated July 24 2023 pursuant to conversion of the Company into public limited Company. The fresh certificate of incorporation consequent to conversion was issued on August 25 2023 by the Registrar of Companies Mumbai.Our corporate identification number is U85195MH2010PLC201078.Major Events and Milestones:2010-Incorporation of our Company.2012-Established new Lab at Kalyan2016-NABL Accreditation at Airoli Centre2018-Established new Lab at Thane2021-NABL Accreditation for SARS-COV-2 testing-Signed up agreements for Diagnostic Centre at Kharghar2022-Signed up agreements for Diagnostic Centre at Panvel / Badlapur2023-Converted Company to Limited-Established new Lab at Murbad

Read More

Clinitech Laboratory Management

NamePosition
Mr. Jagdish Umakant Nayak Chairman & Managing Director
Mrs. Jyoti Jagdish Nayak Whole Time Director
View More

Clinitech Laboratory FAQs

The Buying Price of Clinitech Laboratory share is 38 For live prices and instant trading, you can log in to your Choice trading account or open a Free Demat account with Choice.

To buy Clinitech Laboratory stocks, log in to your Choice trading account. If you don’t have one, open a Choice Demat account. Then, add funds, search for Clinitech Laboratory, choose your preferred order type, and place the trade.

The Price-to-earnings (P/E) ratio of Clinitech Laboratory shares is 0. You can compare it with the sector average for relative valuation.

The Price to Book (P/B) ratio Clinitech Laboratory shares is 0. Useful to assess the stock's value relative to its book value.

To assess Clinitech Laboratory’s valuation compare Sector P/E, P/B which are 48.82 & -16.74 with sector averages, along with growth rates and financial metrics.

The Market Cap of Clinitech Laboratory is 8.44 CR. It indicates the company's size category and trading liquidity.

The 52 week high and low prices of Clinitech Laboratory share price is 57.00 & 28.55. They indicate price extremes, trading ranges, volatility measures, potential support/resistance, and price momentum.

Clinitech Laboratory belongs to the Healthcare sector.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost